NCT00114595View on ClinicalTrials.gov

Ethyl-Eicosapentaenoic Acid and Tardive Dyskinesia

PHASE4CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

April 30, 2003

Study Completion Date

March 31, 2005

Conditions
DyskinesiaSchizophrenia
Interventions
DRUG

eicosapentaenoic acid

Trial Locations (1)

7500

Department of Psychiatry, Department of Health sciences, University of Stellenbosch, Cape Town

All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

lead

University of Stellenbosch

OTHER

NCT00114595 - Ethyl-Eicosapentaenoic Acid and Tardive Dyskinesia | Biotech Hunter | Biotech Hunter